Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis.

ABSTRACT:

SUBMITTER: Sugiyama M 

PROVIDER: S-EPMC8892364 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature